IP Library Granted Patent US 7,019,020
Granted Patent B2
US 7,019,020 · App. 10/467,430 · Granted Mar 28, 2006

2-benzoxazolyl benzene derivatives and their use as UV screening agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,019,020
App. No.
10/467,430
Granted
Mar 28, 2006
Kind
B2
Abstract

Novel benzoxazolyl benzene derivatives of formula (I): wherein R 1 is hydrogen, C 1-20 -alkyl or C 2-20 -alkenyl; R 2 and R 3 are independently a group —C(R 4 ,R 5 )C(R 6 )═C(R 7 ,R 8 ) (a) or a group —C(R 4′ ,R 5′ )CH(R 6′ )CH(R 7′ ,R 8′ ) (b), wherein R 4 , R 5 , R 6 , R 7 , R 8 , R 4′ , R 5′ , R 6′ , R 7′ and R 8′ are independently, hydrogen, C 1-10 -alkyl or C 2-10 -alkenyl, or C 2-10 -alkyl or C 3-10 -alkenyl containing at least one oxygen atom interrupting the hydrocarbon chain; or wherein R 4 , R 5 , R 6 , R 4′ , R 5′ and R 6′ are hydrogen, C 1-10 -alkyl or C 2-10 -alkyl containing at least one oxygen atom interrupting the hydrocarbon chain, or alkyl substituted by silane or oligosiloxane moiety, and one of R 7 and R 8 or R 7′ and R 8′ is a silane or oligosiloxane moiety and the other one of R 7 and R 8 or R 7′ and R 8′ is hydrogen; and X is phenylene or naphthylene, or substituted phenylene or naphthylene for use as UV screening agents for protecting human skin or hair against radiation, and in UV screening compositions, particularly topical compositions for cosmentic or dermatological use.

Claims (21)

1. A compound of formula I

wherein

R 1 is hydrogen, C 1-20 -alkyl or C 2-20 -alkenyl;

R 2 and R 3 are independently a group —C(R 4 , R 5 )C(R 6 )═C(R 7 ,R 8 ) (a) wherein R 4 , R 5 , R 6 R 7 and R 8 are independently, hydrogen, C 1-10 -alkyl or C 2-10 -alkenyl; or C 2-10 -alkyl or C 3-10 -alkenyl containing at least one oxygen atom interrupting the hydrocarbon chain; or wherein R 4 , R 5 and R 6 are hydrogen, C 1-10 -alkyl or C 2-10 -alkyl containing at least one oxygen atom interrupting the hydrocarbon chain, or alkyl substituted by a silane or oligosiloxane moiety, and one of R 7 and R 8 is a silane or oligosiloxane moiety and the other one of R 7 and R 8 is hydrogen; or a group —C(R 4′ ,R 5′ )CH(R 6′ )CH(R 7′ ,R 8′ ) (b), wherein R 4′ , R 5′ and R 6′ are hydrogen, C 1-10 -alkyl or C 2-10 -alkyl containing at least one oxygen atom interrupting the hydrocarbon chain, or alkyl substituted by silane or oligosiloxane moiety, and one of R 7′ and R 8′ is a silane or oligosiloxane moiety and the other one of R 7′ and R 8′ is hydrogen; and

X is phenylene or naphthylene, or substituted phenylene or naphthylene.

2. A compound according to claim 1 wherein X is p-phenylene.

3. A compound of formula I

wherein R 1 , R 2 or are a lipophilic or sterically hindered substituent selected from the group consisting of silane moieties, oligosiloxane moieties, and alkenvl groups having 5 or more carbon atoms.

4. A compound according to claim 1 wherein R 2 and R 3 are a group (a).

5. A compound according to claim 1 wherein R 2 and R 3 are a group (b).

6. A compound selected from the group consisting of 1,4-Bis-[2-(5-tert.-butyl-7-allyl-benzoxazol)-yl]-benzene 1,4-bis-[2-(5-tert.-butyl-7-{3-(1,1,3,3,3-pentamethyl-disiloxanyl)-1-propyl}-benzoxazol)-yl]-benzene; 1,4-bis-[2-(7-{3-(1,1,3,3,3-pentamethyl-disiloxanyl)-1-isobutyl}-benzoxazol)-yl]-benzene; 1,4-bis-[2-(5-tert.-butyl-7-methallyl-benzoxazol)-yl]-benzene; 1,4-bis-[2-(5-tert.-butyl-7-{3-(1,3,3,3-tetramethyl-1-[(trimethyl-silyl)-oxy]-disiloxanyl)-1-isobutyl}-benzoxazol)-yl]-benzene; 1,4-bis-[2-(5-methyl-7-oct-3-en-2-yl-benzoxazol)-yl]-benzene; 1,4-bis-[2-(5-tert.-butyl-7-(1-penyl-allyl)-benzoxazol)-yl]-benzene; 1,4-bis-(2-(5-tert.-butyl-7-oct-3-en-2-yl)-benzoxazol)-yl]-benzene; 1,4-bis-[2-(5-tert.-butyl-7-oct-3-en-2-yl-benzoxazol)-yl]-benzene; and 1,4-bis-[2-(4-tert.-pentyl-7-(1-pentyl-allyl)-benzoxazol)-yl]-benzene.

7. A UV screening composition which comprises as the UV screening agent a compound of formula I according to claim 1 .

8. A compound according to claim 4 wherein R 2 and R 3 are independently a group —C(R 4 ,H)C(H)═C(H,R 8 ) wherein R 4 and R 8 are C 1-10 -alkyl.

9. A compound according to claim 4 wherein R 2 and R 3 are independently a group —C(R 4 ,H)C(H)═CH 2 wherein R 4 is C 1-10 -alkyl.

10. A compound according to claim 5 wherein R 2 and R 3 are independently a group —C(R 4′ ,H)CH═CH(H,R 8′ ) wherein R 4′ is selected from the group consisting of hydrogen, C 1-10 -alkyl, C 2-10 -alkyl containing at least one oxygen atom interrupting the hydrocarbon chain, alkyl substituted by a silane moiety, and alkyl substituted by an oligosiloxane moiety, and R 8′ is oligosiloxane moiety.

11. A compound according to claim 5 wherein R 2 and R 3 are independently a group CH 2 CH(R 6′ )CH(H,R 8′ ) wherein R 6′ is C 1-10 -alkyl and R 8 ′ is an oligosiloxane moiety.

12. A compound according to claim 3 wherein R 1 R 2 or R 3 are a lipophilic or a sterically hindered substituent selected from the group consisting of

silane moieties —SiR a R b R c , wherein R a , R b and R c each independently are C 1 –C 6 -alkyl or phenyl,

oligosiloxane moieties of the general formula IVa, lVb and lVc

wherein m=0, 1 or 2; n=1, 2 or 3 and m+n=3, R a and R b are C 1 –C 6 -alkyl or phenyl, and r is an integer from 1 to 9, and

3-octen-2-yl, 1-octen-3-yl, and 2-octenyl.